University of Sheffield: Scientists Prove Low Cost Arthritis Drug Can Be Used to Effectively Treat Blood Cancer Sufferers
September 19, 2019
September 19, 2019
SHEFFIELD, England, Sept. 19 [TNSmedicalresearch] -- The University of Sheffield issued the following news:
A simple arthritis drug could be an effective, low cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET), a breakthrough study by the University of Sheffield has shown.
Led by Dr Martin Zeidler, from the University of Sheffield's Department of Biomedical Science and Dr Sebastian Francis from the Depart . . .
A simple arthritis drug could be an effective, low cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET), a breakthrough study by the University of Sheffield has shown.
Led by Dr Martin Zeidler, from the University of Sheffield's Department of Biomedical Science and Dr Sebastian Francis from the Depart . . .